Wockhardt has received USFDA approval to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. Wockhardt Bio AG had filed this abbreviated new drug application (ANDA) in collaboration with Fresinius Kabi, Italy (FKAI) where the product development was completed. The ANDA will be manufactured commercially at FKAI, Mitim, Italy.
Company Profile : Wockhardt Ltd
Leave a Reply